Neurology® Podcast

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan and Dr. Myla Goldman interview Dr. Douglas Goodin about his paper on the use of natalizumab (tysabri) for treatment of multiple sclerosis. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Alexandra Degenhardt interviewing Dr. Neil Lava about practical aspects of natalizumab administration for the Lesson of the Week segment. The participants had nothing to disclose except for Dr. Goodin and Dr. Lava.Dr. Goodin has received honoraria for lectures or as a consultant (directly or indirectly) from Teva Neuroscience, Biogen/Idec, Merck-Serono, Bayer-Schering Healthcare and Berlex Laboratories. Dr. Goodin has received research support from Biogen-Idec, Bayer-Schering and Novartis. Dr. Lava received grants for research in the Sentinel Study.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Neeraj Kumar and Jason Mackey interview Drs. Sharon Nations and Jaya Trivedi about their paper on denture cream: an unusual source of excess zinc. The podcast concludes with Dr. Amy Kahn interviewing Dr. Neeraj Kumar about heavy metals for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Juliana Lockman and Alan Ettinger interview Dr. Ley Sander about his paper on drowning in people with epilepsy. The podcast concludes with Dr. Ted Burns interviewing Dr. Sheldon Horowitz about maintenance of certification for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Drs. Andrew Lees from UK and Regina Katzenschlager from Austria about their trial comparing three initial treatments for Parkinson disease. In this additional segment for this issue, Dr. Overman is introducing a new feature called 'e-pearls' which are brief educational points-pearls-that are often, though not necessarily always, tied to a Neurology article, podcast, or item on the website. The length of each E-Pearl is short and tailored to be read and absorbed within a few minutes. E-pearls are mailed to residents and fellows but in the future we hope to have them available on the website.The podcast concludes with a Clinical Pearl session where Dr. Ryan Overman interviews Dr. S. Nizam Ahmed. Podcast participants had nothing to disclose except for Drs. Lees and Katzenschlager. Dr. Lees received fees for speaking consulting and organizing educational events from Britannia and Novartis. Dr. Katzenschlager received unrestricted grants during first years of this study and fees for speaking and organizing educational events from Britannia and Novartis.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar and Dr. Bud Rowland interview Dr. Don Sanders about his papers describing the results of two recently completed RCT of cellcept in myasthenia gravis. The podcast concludes with Dr. Ted Burns interviewing Dr. Gary Cutter about outcome measures for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Geldmacher interview Drs. Caryn Cramer and Mary Haan from the Department of Epidemiology at the University of Michigan about their paper on use of statins in a cohort study. The podcast concludes with Dr. Julian Bragg interviewing Dr. Susanne May about Cox proportional hazards modeling. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Peter Kang interview Dr. Jerry Mendell, Director, Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital about his paper on gene therapy as a potential treatment for LGMD. The podcast concludes with Dr. Erik Ensrud interviewing Dr. Steve Karceski on the topic of translational research efforts. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. E. Clarke Haley and Brett Kissela interview Dr. Juan F. Arenillas about his paper on metabolic syndrome and resistance to IV thrombolysis. The podcast concludes with Dr. Fadi Nahab interviewing Dr. Tanya Turan for the Lesson of the week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Alessandro Adami and Dr. Gian Paolo Anzola about their paper on increased white matter lesion load in migraine with aura patients. The podcast concludes with Dr. Sean Savitz interviewing Dr. Shunichi Homma for the Lesson of the week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann and Dr. Chris White interview Dr. Thomas Bird about his paper on hereditary axonal neuropathies. The podcast concludes with Dr. Ted Burns interviewing Dr. Peter Dyck about two 1968 landmark publications that led to the commonly-used classification scheme for inherited neuropathies. The participants had nothing to disclose except for Dr. Thomas Bird. Dr. Thomas Bird receives Licensing Fees from Athena Diagnostics Inc and one of the co-authors of the paper, Dr. William Seltzer, is employed as Laboratory Director of Athena Diagnostics.)

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Orly Avitzur interview Dr. James Bernat and Dr. Daniel Larriviere about their paper on threats to physician autonomy. The podcast concludes with Dr. Ryan Overman and Dr. Shanna Patterson interviewing Dr. Bradley Boeve for the first installment of a new series of podcasts called "E-Pearls" which discussed Balint's syndrome. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Beau Bruce interview Dr. Brian G. Weinshenker, Professor of Neurology from the Mayo Clinic about his team's paper on NMO-IgG predicts outcome of recurrent optic neuritis. The podcast concludes with Dr. Ted Burns interviewing Dr. Robert J. Joynt, Section Editor for the Changes People Comments Section with one to be published in this issue. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Kevin Barrett and Dr. Ryan Overman interview Dr. Terry Fife of the Barrow Neurological Institute and University of Arizona and Dr. Gary Gronseth of the University of Kansas about their practice parameter on benign paroxysmal positional vertigo therapies. The podcast concludes with Dr. Marat Reyzelman interviewing Dr. Sharon Hartman Polensek for the Lesson of the week on the topic of positioning maneuver for horizontal canal BPPV. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Erik Ensrud and Dr. Jason Mackey interview Dr. John Steele of Guam Memorial Hospital and Dr. Patrick McGeer of the University of British Columbia about their paper on ALS/PDC syndrome of Guam and the cycad hypothesis. The podcast concludes with reposting of Dr. Farah Mateen interviewing Dr. Donald Mulder on his work in Guam back in the fifties (originally heard as part of the January 8 2008 podcast). Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Carolyn Klein interview Dr. Steve Vernino from the University of Texas, Southwestern Medical Center and Dr. Phillip Low form the Mayo Clinic about their paper on autonomic ganglia. The podcast concludes with Dr. Adam Heller interviewing Dr. Roy Freeman on the topic of the autonomic history for the Lesson of the Week. Podcast participants had nothing to disclose except Dr. Freeman. In the past 12 months, Dr Freeman has received consulting fees from Eli-Lilly, Pfizer, Solace, XtlBio, and Chelsea Pharmaceuticals, and honoraria for speaking from Pfizer and Eli-Lilly.Dr. Freeman has received personal compensation for his editorial activities (Editor) with Autonomic Neuroscience - Basic and Clinical.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Anderson and Dr. Michael K. Hehir interview Dr. Anne Lindblad from the EMMES Corporation and Dr. Robert G. Hart from the University of Texas, Health Science Center about their paper on NINDS-sponsored studies. The podcast concludes with Dr. Brandy Fureman interviewing Dr. Walter Koroshetz on the topic of NIH clinical research collaboration for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Richard Lewis interview Dr. Troels Staehelin Jensen from Aarhus University Hospital in Denmark and Dr. Rolf-Detlef Treede from University of Heidelberg in Germany about their paper on neuropathic pain: redefinition. The podcast concludes with Dr. Bernard Chang interviewing Dr. Gary Franklin for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael K. Sowell and Dr. J. D. Bartleson interview Dr. Tamara Pringsheim from Alberta, Canada about her paper on treatment of menstrually related migraine headache. The podcast concludes with a Clinical Pearl session where Dr. Jason Mackey interviews Dr. Elliot Frohman. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Peter Goadsby and Dr. Stephen Silberstein interview Dr. Tony Ho from Merck & Co., Inc. about his paper on oral CGRP antagonist, MK-0974, in acute treatment of migraine. The podcast concludes with Dr. Myla Goldman interviewing Dr. Bruce Levin for Lesson of the Week. The participants had nothing to disclose except for Dr. Silberstein. His Author Disclosure is as follows: Income for speaking, consulting or serving on an advisory board- GlaxoSmithKline, Allergan, AstraZeneca, Endo, Medtronic, Merck, J&J, Pfizer, Pozen, Valeant Pharmaceuticals International (not in excess of $10,000) & Research Support- Allergan (not in excess of $10,000).

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Leslie Jameieh Cloud and Dr. Cynthia Comella interview Dr. Jacques Montplaisir from the Sleep Studies Center at Sacred Heart Hospital in Montreal about his paper on REM sleep behavior disorder. The podcast concludes with Dr. Daniel O. Claassen interviewing Dr. Bradley F. Boeve for Lesson of the Week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns and Dr. David Carr interview Dr. Brian Ott, Professor in the Department of Clinical Neurosciences from Brown Medical School about his paper on drivers with Alzheimer disease. The podcast concludes with Dr. Ted Burns interviewing Dr. Deniz Erten-Lyons, Patient Page Editors, Dr. David Spencer and Dr. Steve Karceski about the Patient Page Section and actual Patient Page published in this issue. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. William S. David and Dr. Steven M. Albert interview Dr. Vincent Meininger, Professor of Neurology at the Saltpetriere in Paris, France about his paper on amyotrophic lateral sclerosis. The podcast concludes with Dr. Richard Leigh interviewing Dr. John Carew for the Lesson of the Week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar and Dr. Beth Lang interview Dr. Francesc Graus from the Hospital Clinic in Barcelona, Spain about his paper on SOX1 antibodies. The podcast concludes with Dr. Harman Bajwa interviewing Dr. Josep Dalmau for Lesson of the Week. Podcast participants had nothing to disclose except for Dr. Dalmau. He has given 1 or 2 talks per year that are sponsored by Athena Diagnostics.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Aman A. Savani and Dr. Thomas Wingo interview Dr. Donald H. Gilden from the University of Colorado about his paper on VZV vasculopathy. The podcast concludes with Dr. Michael Brooke introducing the Humanities section of the journal and then reading three poems by Nina F. Schor published in January 22, 2008 issue. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Justin Sattin and Dr. Kinan K. Hreib interview Dr. Paul Surtees from the University of Cambridge about his paper on depressive disorder and risk of stroke. The podcast concludes with Dr. Robert Hoesch interviewing Dr. Anna Ledegza for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ryan Overman and Dr. Greg Schaublin interview Dr. Paul Brown,recently retired from the National Institutes of Health in Bethesda, MD. The podcast concludes with Dr. Jason Mackey interviewing Dr. Chum Lim for Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Beau Bruce and Dr. Jeremy Lanford interview Dr. Michael Wall from the University of Iowa about his paper on intracranial hypertension. The podcast concludes with Dr. Shanna Patterson interviewing Dr. Virgilio Evidente for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jennifer Bickel and Dr. Rob Armstrong interview Dr. Kathleen Merikangas from the NIH about her paper on the topic of headache-related disability. The podcast concludes with Dr. Sam Ghaffari interviewing Dr. Stephanie Studenski for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan and Dr. Shanna Patterson interview Dr. David J. Thurman from CDC National Center in Atlanta, GA about his practice parameter on the topic of risk of falls. The podcast concludes with Dr. David Polston interviewing Dr. Robert Holloway for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Levy and Dr. Chris Inglese interview Dr. Sean Pittock & Dr. Brenda Banwell about their paper on childhood inflammatory demyelinating CNS disorders. The podcast concludes with Dr. Lee Dresser interviewing Dr. Mark Mullins for Lesson of the week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Laura Tormoehlen interviews Dr. Michael Williams for the Lesson of the week. The podcast concludes with Dr. Jim Bernat and Dr. Dan Larriviere interviewing Dr. David Greer from the Massachusetts General Hospital about his paper about AAN brain death guidelines. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Juliana Lockman and Dr. Matt Stead interview Dr. Raj Sheth from the University of Wisconsin about his paper on bone loss in children with epilepsy. The podcast concludes with Dr. Nick Silvestri interviewing Dr. Vin Tangpricha for the Lesson of the week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Roland More and Dr. Morie Gertz interview Dr. Taro Yamashita from Kumamoto University in Japan about his paper on the effects of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. The podcast concludes with Dr. Farrah Mateen interviewing Dr. Donald Mulder for our first Historical interview. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jaideep Kapur and Dr. Ty Schwertfeger interview Dr. Yitzhak Schiller from Rambam Medical Center, Haifa Israel about his paper on the topic of drug resistance in epilepsy. The podcast concludes with Dr. Crystal Richards interviewing Dr. Robert M. Hoekstra for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Merit E. Cudkowicz and Dr. Branavan Mahadeva interview Dr. Mustafa Hammad from Emory University about his paper on sensory abnormalities in ALS. The podcast concludes with our first Clinical Pearl interview where Dr. Ryan Overman interviews Dr. Janet Rucker. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger and Dr. Bennett Shaywitz interview Dr. Bernard Chang from Harvard Medcial School about his paper on genetic brain malformation. The podcast concludes with Dr. Ted Burns interviewing Martha Barnette for Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Hardy and Dr. Demetrius M. Maraganore interview Dr. Christine Klein from University of Lubeck in Germany and Dr. Michael Schossmacher from University of Ottawa about their paper on alpha-synuclein ten years later. The podcast concludes with Dr. Bryan Traynor interviewing Dr. Sonja Scholz for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Croom and Dr. Jonathan Marcus interview Dr. Allan Krumholz from the University of Maryland and Dr. Gary Gronseth from the University of Kansas about their practice parameter on unprovoked first seizure in adults. The podcast concludes with Dr. Adam Heller interviewing Dr. Gary Gronseth for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brad Worrall & Dr. Bernadette Boden-Albala interview Dr. Amytis Towfighi from University of California at Los Angeles about her paper on midlife stroke surge among women in the U. S. The podcast concludes with Dr. Justin Sattin interviewing Dr. Kathryn S. Porter for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Hurtig and Dr. David A. Schoenfeld interview Dr. Beate Ritz from UCLA about her paper on nonsteroidal anti-inflammatory drugs. The podcast concludes with Dr. Lee I. Kubersky interviewing Dr. Carmel Armon for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Blaise Bourgeois & Dr. Nathan Fountain interview Dr. Samuel Berkovic from the Epilepsy Research Center University of Melbourne, Australia about his paper studying the use of levetiracetam in patients with idiopathic generalized epilepsy. The podcast concludes with Dr. Andrew Tarulli interviewing Dr. Michael J. Lynn for the Lesson of the Week. Podcast participants had nothing to disclose except for Drs. Berkovic and Bourgeois. Dr. Berkovic has received grants in excess of $10,000 and honoraria not in excess of $10,000 from UCB Pharma SA, who were involved in the design and conduct of the study; collection, management, and analysis of the data; and preparation and review of the manuscript. Dr. Bourgeois has received grant support or consulting fees from Abbott, Eisai, Elan Pharmaceuticals, Ortho-McNeil, Novartis, Ovation Pharma, and UCB Pharma in excess of $10,000.The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Sladky & Dr. Guillermo Solorzano interview Dr. Irving Nachamkin and Dr. Arthur Asbury from University of Pennsylvania School of Medicine about their paper on patterns of GBS in children. The podcast concludes with Dr. Michelle Mauerman interviewing Dr. Hugh Willison for the Lesson of the Week. Podcast participants have nothing to disclose. The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar & Dr. Sung Bae Lee interview Dr. Jeffrey Cummings from UCLA about his paper on disease-modifying therapies for AD. The podcast concludes with Dr. John Carew interviewing Dr. Wiliam Jagust for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns and Dr. John Morris interview Dr. Marson about his paper on mild cognitive impairment and medical decision-making. The podcast concludes with Dr. Daniel Press interviewing Dr. John Morris about mild cognitive impairment. Podcast participants had nothing to disclose except for Dr. Daniel Marson who received royalties from the UAB Research Foundation which owns the capacity outcome measure used in this study. The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Freedman & Dr. Ellis Hedaya interview Dr. Peter Calabresi from John Hopkins University about his paper on anti-natalizumab antibodies. The podcast concludes with Dr. Robb M. Snider interviewing Dr. James J. Lah for the Lesson of the Week. Podcast participants had nothing to disclose except for Dr. Peter Calabresi whohas received grant support in excess of $10,000 from Biogen Idec for other research/activities not reported in this article and honoraria from Biogen Idec in excess of $10,000/year. The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Kiely and Dr. Shanna Patterson interview Dr. Schiff about his paper on low-grade glioma. The podcast concludes with Dr. Lori Schuh interviewing Dr. Jennifer Quinn for the Lesson of the Week. Podcast participants had nothing to disclose except for Dr. David Schiff who has given lectures through the Schering-Plough Speaker's Bureau and served as a consultant to Schering-Plough.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Galvin and Dr. Juliana Lockman interview Dr. Nikos Scarmeas from Columbia University about his paper on Alzheimer disease and the Mediterranean Diet. The podcast concludes with Dr. Ted Burns interviewing Dr. Gary Cutter for our first Lesson of the Week. Podcast participants had nothing to disclose.

This first Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment, Dr. Ted M. Burns and Dr. Karen Roos interview Dr. Frederick Blanc from France about his paper on antibody index testing for Lyme disease. The podcast concludes with Dr. Ted M. Burns providing an overview and background of the Neurology podcast initiative and an introduction to the podcast committee and other upcoming initiatives for future podcasts.